Jump To
Healthcare Industry Trends
Key takeaways
Our Healthcare Investments and Exits report shows a surge in biotech AI investment, strong early-stage momentum and mixed signals from valuation trends.
$5.6B
Invested in biotech AI in 2024
Driven largely by mega-deals, investment in biotech AI nearly tripled.
Nearly 40%
Of all healthcare deals with a declared Series went to seed-stage companies
Seed and Series A rounds claimed a majority of healthcare deals in 2024.
1
Number of healthcare subsectors experiencing a drop in down and flat rounds
Market corrections may be starting to wind down in biotech, devices and diagnostics/tools.
The data
2024 was a banner year for biotech, with significant investments in AI-powered drug discovery and protein engineering and fewer down and flat rounds. Though M&A activity is muted, the IPO market is promising. A handful of companies have already filed for IPOs in 2025, and decent performances from companies that debuted in 2024 should build confidence.
Biotech AI investment outpaces 2021
With protein discovery and structure platforms leading the space, biotech AI was one of the very few tech groups that surpassed their 2021 investment levels.
The biggest impacts of AI are still emerging and most clinical trials take at least five years, so VCs are investing now with an eye toward putting themselves on the cutting edge later this decade.
Early-stage rounds are taking off
A majority of deals with a declared Series in 2024 went to Series A and seed-stage companies, with seed rounds alone accounting for nearly 40% of total deals.
This early-stage momentum was most significant in healthtech, where seed deals outnumbered Series A deals two to one.
Down rounds have begun to level off
Down and flat rounds have decreased for biopharma, and levelled off in other sectors for the first time in four years.
However, the number of undisclosed rounds has increased, suggesting market valuations may still be resetting.
Explore other First Citizens Innovation Banking Reports
Reports
The Future of Healthtech 2026
Nov 09, 2026
Megan Scheffel, Adam Tweedy, Dennis He, Matt Donne, Alex Lennox-Miller, Urbashee Paul, Josh Pherigo
Reports
The Future of Fintech 2026
Oct 13, 2026
Nick Christian, Brian Foley, Julie Wagne, Sophie McNaught, Josh Pherigo, Eli Oftedal, Andrew Pardo
Reports
The Future of Climate Tech
Apr 15, 2026
Jordan Kanis, Eli Oftedal, Josh Pherigo, Andrew Pardo